Unlike Tregs, surface expression of CTLA-4 by both naïve and anti-tumor CD4+ and CD8+ effector memory T cells only occurs following major histocompatibility complex (MHC)-dependent activation of these cells by APCs. This evidence concerns the gene CD8A and neoplasm.